Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways1. Issue 3 (11th March 2015) - Lai, Haoqiang
Abstract A series of ruthenium(ii) benzimidazole complexes has been synthesized and identified as antiangiogenic agents with distinct structure-based action mechanisms.